Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Impact of the Cilioretinal Artery on Retinal Vessel Density in Eyes with Age-related Macular Degeneration
Author Affiliations & Notes
  • Alan Goto
    University of California Davis, Davis, California, United States
  • Carol Villafuerte-Trisolini
    University of California Davis, Davis, California, United States
  • Alexander Rusakevich
    University of California Davis, Davis, California, United States
  • Sophie Lee
    University of California Davis, Davis, California, United States
  • Parisa Emami-Naeini
    University of California Davis, Davis, California, United States
  • Ala Moshiri
    University of California Davis, Davis, California, United States
  • Susanna S Park
    University of California Davis, Davis, California, United States
  • Glenn Yiu
    University of California Davis, Davis, California, United States
  • Footnotes
    Commercial Relationships   Alan Goto None; Carol Villafuerte-Trisolini None; Alexander Rusakevich None; Sophie Lee None; Parisa Emami-Naeini Bausch and Lomb, Eyepoint, Genentech, Code C (Consultant/Contractor), Genentech, Code F (Financial Support); Ala Moshiri None; Susanna Park None; Glenn Yiu 4DMT, Abbvie, Adverum, Alimera, Bausch & Lomb, Boehringer Ingelheim, Clearside, Endogena, Genentech, Gyroscope, Intergalactic, Iridex, Janssen, jCyte, Myrobalan, NGM Bio, Novartis, Ray, Regeneron, RegenXBio, Stealth, Thea, Topcon, Zeiss, Code C (Consultant/Contractor)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 812. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Alan Goto, Carol Villafuerte-Trisolini, Alexander Rusakevich, Sophie Lee, Parisa Emami-Naeini, Ala Moshiri, Susanna S Park, Glenn Yiu; Impact of the Cilioretinal Artery on Retinal Vessel Density in Eyes with Age-related Macular Degeneration. Invest. Ophthalmol. Vis. Sci. 2024;65(7):812.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : In eyes with age-related macular degeneration (AMD), the presence of a cilioretinal artery (CRA) and higher retinal vessel density (VD) are associated with lower risk of choroidal neovascularization (CNV). Here, we determine whether VD as measured on OCT angiography (OCT-A) may account for the protective effect of the CRA against exudative AMD.

Methods : We performed a retrospective, cross-sectional analysis of 435 eyes of 247 patients diagnosed with AMD at the University of California, Davis between January 27, 2017 and February 28, 2019 to determine CRA presence from fluorescein angiography (FA), color fundus photography (CFP), or infrared reflectance (IR), and measured retinal vascular perfusion including VD within the foveal 1mm subfield, parafoveal 1-3mm ring, and full 3mm macular field, as well as foveal avascular zone (FAZ) area, perimeter, and circularity. We determined associations between age, CRA presence, or AMD subtype with VD or FAZ parameters using logistic regressions with generalized estimating equations.

Results : We found 48 of 435 (11.0%) eyes had a CRA. VD decreased with age in the foveal (B = -.224, P < 0.001), parafoveal (B = -.244, P < 0.001), and macular (B = -.229, P < 0.001) regions, but were not associated with the presence of a CRA (P = 0.526 - 0.911). FAZ area (P = 0.014), perimeter (P = 0.010), and circularity (P = 0.046) also worsened with older age, but was not affected by CRA presence (P = 0.112 - 0.736). Eyes with exudative AMD exhibited lower parafoveal (29.8% ± 6.3% vs. 33.0% ± 5.7%, P < 0.001) and macular VD (27.9% ± 6.2% vs. 31.2% ± 5.5%, P < 0.001), regardless of CRA status.

Conclusions : Although CRA presence and higher VD are both associated with a lower prevalence of CNV, eyes with CRA do not exhibit higher VD, suggesting that the protective effect of a CRA is not mediated by greater retinal perfusion in the macula.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×